Sign In to Follow Application
View All Documents & Correspondence

An Improved Process For The Preparation Of 4 Acetyl 2 Methyl Benzonitrile

Abstract: ABSTRACT AN IMPROVED PROCESS FOR THE PREPARATION OF 4-ACETYL-2-METHYL-BENZONITRILE The present invention relates to an improved process for the preparation of 4-acetyl-2-methyl-benzonitrile of formula (I). The present invention further provides an improved process for the preparation of isoxazoline derivatives using 4-acetyl-2-methyl-benzonitrile of formula (I) obtained by a process described herein.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
30 June 2023
Publication Number
14/2025
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

Hikal Limited
3A & 3B, International Biotech Park Hinjewadi, Pune Maharashtra India 411 057

Inventors

1. RAMA SHANKAR
Hikal Limited, 3A & 3B, International Biotech Park, Hinjewadi, Pune Maharashtra India 411 057
2. NIMESH CHANDRA
Hikal Limited, 3A & 3B, International Biotech Park, Hinjewadi, Pune Maharashtra India 411 057
3. RAVINDRA LANDGE
Hikal Limited, 3A & 3B, International Biotech Park, Hinjewadi, Pune Maharashtra India 411 057
4. NISAR SAYYAD
Hikal Limited, 3A & 3B, International Biotech Park, Hinjewadi, Pune Maharashtra India 411 057
5. RAHUL PATIL
Hikal Limited, 3A & 3B, International Biotech Park, Hinjewadi, Pune Maharashtra India 411 057
6. MONISH MORE
Hikal Limited, 3A & 3B, International Biotech Park, Hinjewadi, Pune Maharashtra India 411 057

Specification

DESC:FORM 2
THE PATENT ACT, 1970
(39 of 1970)
COMPLETE SPECIFICATION
(See section 10; rule 13)

“AN IMPROVED PROCESS FOR THE PREPARATION OF 4-ACETYL-2-METHYL-BENZONITRILE”

HIKAL LIMITED, AN INDIAN COMPANY OF 3A & 3B, INTERNATIONAL BIOTECH PARK, HINJEWADI, PUNE – 411057, MAHARASHTRA, INDIA

The following specification describes the invention and the manner in which it is to be performed.

IELD OF THE INVENTION
The present invention relates to an improved process for the preparation of 4-acetyl-2-methyl-benzonitrile of formula (I). The present invention further provides an improved process for the preparation of isoxazoline derivatives using 4-acetyl-2-methyl-benzonitrile of formula (I) obtained by a process described herein.

BACKGROUND OF THE INVENTION

The 4-acetyl-2-methyl-benzonitrile is a key intermediate for preparing isoxazoline derivatives such as Fluralaner, Lotilaner, Afoxolaner and Fluxametamide.
Several patent publications such as WO2011104089, WO2023012821, CN109553528 have disclosed the preparation of 4-acetyl-2-methyl-benzonitrile and its use in preparation of isooxazoline derivatives.
The synthetic process described in prior arts for the preparation of 4-acetyl-2-methyl-benzonitrile suffer from disadvantages mainly such as: i) use of expensive cyanide reagent such as potassium ferrocyanide; ii) use of phase transfer catalyst; iii) troublesome operation; iv) tedious workup and isolation technique; v) industrially non-accepted column chromatography for purification; v) excess polymerisation or degradation of compound; vi) low yield and purity.
Generally, the efforts in achieving complete reaction conversion, non-degradation, and/or avoiding polymerization of desired compound along with good yield and purity is a challenge for an industry which remarkably affects the overall production cost. However, the inventors of the present invention developed a process which avoids the polymerization or degradation of compound and leads to complete reaction conversion along with high purity and greater yield.
The application of intermediate of formula (I) which is obtained by the invented process is used for preparation of isooxazoline derivatives as shown below.

Wherein T and Y each independently represent a substituted aryl or a substituted heteroaryl,
X represents a hydrogen atom or a halogen atom.

The inventors of instant invention have developed an improved process for the preparation of 4-acetyl-2-methyl-benzonitrile to overcome the limitations of the prior arts in cost effective and industrially convenient way in high yield (>73%) in less cycle time with greater chemical purity (99%). The instant process is performed on an industrial scale by using commercially available key raw materials such as 3-Methyl-4-fluoroacetophenone, sodium cyanide and a chelating agent such as citric acid. The instant process involves the simple reactions conditions, isolation, and purification technique to obtain desired compound in pale yellow solid with better yield and good purity. The 4-acetyl-2-methyl-benzonitrile obtained using said process is further utilized for the preparation of isoxazoline derivatives such as Fluralaner as disclosed in WO2013/021949 which is incorporated herein for reference.
SUMMARY OF THE INVENTION

In one aspect of the present invention provides a process for the preparation of 4-acetyl-2-methyl-benzonitrile of formula (I)

by reacting 3-methyl-4-haloacetophenone, where halo is fluorine, chlorine, bromine, and Iodine with a solution consisting of sodium cyanide, chelating agent in a polar aprotic solvent.

In another aspect, the present invention provides a 4-acetyl-2-methyl-benzonitrile having purity greater than 99%; more preferably greater than 99.5% as measured by HPLC.

In another aspect, the present invention relates to a process for the preparation of 4-acetyl-2-methyl-benzonitrile comprising the steps of:
i) preparing a solution of sodium cyanide, chelating agent in a polar aprotic solvent,
ii) heating a solution of step (a) at 65°C to 90°C,
iii) adding 3-methyl-4-haloacetophenone of formula (II)

iv) heating the reaction mixture of step (iii) at 90°C to 120°C,
v) cooling the reaction mixture of step (iv),
vi) filtering, and
vii) recrystallisation the compound obtained in step (vi) using alcoholic solvent or hydrocarbon solvent.
In another aspect of the present invention provides an improved process for the preparation of Fluralaner using 4-acetyl-2-methyl-benzonitrile of formula (I) obtained by a process described herein, where the process for preparation of Fluralaner is followed by a skilled person as illustrated in WO2013021949.

DETAILED DESCRIPTION OF THE INVENTION

The present invention now will be described more fully hereinafter. As used herein, the terms "comprises," "comprising," "includes," "including," "has," "having," "contains" or "containing," or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, a mixture, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or apparatus. Further, unless expressly stated to the contrary, "or" refers to an inclusive or and not to an exclusive. As used in the specification, and in the appended claims, indefinite articles "a" and "an" preceding an element or component of the invention are intended to be nonrestrictive regarding the number of instances (i.e., occurrences) of the element or component. Therefore "a" or "an" should be read to include one or at least one, and the singular word form of the element or component also includes the plural unless the number is obviously meant to be singular indicates otherwise.

The term ‘solvent’ used herein, refers to the single solvent or mixture of solvents.

The compound 4-acetyl-2-methyl-benzonitrile of formula (I) prepared by using the process described herein results purity having greater than 99%, preferably greater than 99.5%, and substantial percentage of known or unknown impurity as measured by HPLC.

The substantial percentage used herein refers to a maximum acceptable percentage by the regulatory authority for known or unknown impurity(es).

In accordance with the aspect of the present invention, the process for preparation of 4-acetyl-2-methyl-benzonitrile of formula (I), which comprises:
step (a) reacting a 3-methyl-4-haloacetophenone with a solution containing sodium cyanide, chelating agent such as citric acid in presence of polar aprotic solvent;
step (b) isolating; and
step (c) recrystallization in alcoholic solvent or hydrocarbon solvent or combination thereof resulting in good yield (>73%) and better purity (>99.5%).

In another embodiment of the present invention, wherein the use of chelating agent avoids impurity formation, polymerization, and degradation of reaction mass.

In another embodiment of the present invention, wherein chelating agent uses in catalytic amount, which is selected from citric acid, Ethylenedinitrilo-tetraacetic acid (EDTA), Nitrilotriacetic acid (NTA), meso-2,3-dimercaptosuccinic acid (DMSA), and Gluconic Acid.

In another embodiment of the present invention, wherein citric acid is used in 1 to 5 %w/w ratio with respect to 3-methyl-4-haloacetophenone.

In another embodiment of the present invention, wherein the reaction is performed at a temperature of 80°C to 120°C and for 10-20 hours.

In another embodiment of the present invention, wherein isolation step is performed by addition of water in reaction mixture, filtration, and subsequent purification by recrystallization.

In another embodiment of the present invention, wherein recrystallisation is performed using alcoholic solvent or hydrocarbon solvent or mixture thereof.

In another embodiment of the present invention, wherein recrystallisation process is comprising steps of:
i) adding compound of step (b) in an alcoholic solvent or hydrocarbon solvent or mixture thereof.
ii) heating the reaction mass till clear solution at 45 to 65°C for 1-2 hrs,
iii) gradually cooling the reaction solution to from 65°C to -5°C and maintaining for 1-2 hrs,
iv) filtering the compound to obtain 4-acetyl-2-methyl-benzonitrile.
In another embodiment of the present invention, wherein polar aprotic solvent is selected from ethyl acetate, acetonitrile, dimethylformamide, dimethyl sulfoxide and the like; preferably dimethyl sulfoxide.

In another embodiment of the present invention, wherein alcoholic solvent is selected from methanol, ethanol, isopropanol, and the like.

In another embodiment of the present invention, wherein hydrocarbon solvent is selected from toluene, hexane, pentane, cyclohexane and the like.

The compound 4-acetyl-2-methyl-benzonitrile of formula (I) obtained by the process described herein is further used for the preparation of Fluralaner.

The preparation of the starting materials and reagents used in the present invention are well known in prior art.

The process for the preparation of 4-acetyl-2-methyl-benzonitrile of formula (I) is illustrated in the following synthetic scheme.

The invention is further illustrated by the following examples, which should not be construed to limit the scope of the invention in anyway.

EXPERIMENTAL
Preparation of 4-acetyl-2-methyl-benzonitrile (I)
To a solution of dimethyl sulfoxide (4-6V), citric acid (1-5%w/w), sodium cyanide (1-1.2eq) was added and heated at 70°C to 95°C for 1-2 hrs. To the above solution 3-methyl-4-fluoroacetophenone (1.0 eq) was added and the reaction mixture was heated at 100°C to 120°C for 10-20 hrs. The completion of reaction is monitored by HPLC. After completion, the reaction mixture was cooled to 15°C to 25°C and quenched by adding water. The solid compound was filtered to obtain crude compound with HPLC purity > 91%. To the crude compound ethanol solvent was added and heated at 50°C to 60° for 1-2 hrs. The clear solution was gradually cooled to room temperature and further cooled to 0°C to -5°C and maintained for 1-2 hrs. The compound was filtered, dried to obtain 4-acetyl-2-methyl-benzonitrile (73% yield, HPLC purity: 99.5%, unknown impurities < 0.5%).
,CLAIMS:We claim:

1) A process for the preparation of 4-acetyl-2-methyl-benzonitrile of formula (I)

by reacting 3-methyl-4-haloacetophenone compound of formula (II)

with a solution consisting of sodium cyanide, chelating agent in a polar aprotic solvent.

2) The process for the preparation of 4-acetyl-2-methyl-benzonitrile of formula (I)
as claimed in claim 1 comprising the steps of :
i) preparing a solution of sodium cyanide, chelating agent in a polar aprotic solvent,
ii) heating a solution of step (a) at 65°C to 90°C,
iii) adding 3-methyl-4-haloacetophenone of formula (II)

iv) heating the reaction mixture of step (iii) at 90°C to 120°C,
v) cooling the reaction mixture of step (iv),
vi) filtering, and
vii) recrystallizing the compound obtained in step (vi) using alcoholic solvent or hydrocarbon solvent or mixture thereof.

3) The process as claimed in claim 1, wherein chelating agent is selected from citric acid, Ethylenedinitrilo-tetraacetic acid (EDTA), Nitrilotriacetic acid (NTA), meso-2,3-dimercaptosuccinic acid (DMSA), and Gluconic Acid.

4) The process as claimed in claim 1, wherein polar aprotic solvent is selected from ethyl acetate, acetonitrile, dimethylformamide, dimethyl sulfoxide; alcoholic solvent is selected from methanol, ethanol, isopropanol; and hydrocarbon solvent is selected from toluene, hexane, pentane, and cyclohexane.

5) The process as claimed in claim 1, wherein chelating agent is used in a 1-5% w/w.

Documents

Application Documents

# Name Date
1 202321044177-STATEMENT OF UNDERTAKING (FORM 3) [30-06-2023(online)].pdf 2023-06-30
2 202321044177-PROVISIONAL SPECIFICATION [30-06-2023(online)].pdf 2023-06-30
3 202321044177-POWER OF AUTHORITY [30-06-2023(online)].pdf 2023-06-30
4 202321044177-FORM 1 [30-06-2023(online)].pdf 2023-06-30
5 202321044177-DECLARATION OF INVENTORSHIP (FORM 5) [30-06-2023(online)].pdf 2023-06-30
6 202321044177-Proof of Right [08-08-2023(online)].pdf 2023-08-08
7 202321044177- ORIGINAL UR 6(1A) FORM 1-140823.pdf 2023-09-29
8 202321044177-CORRESPONDENCE-OTHERS [27-06-2024(online)].pdf 2024-06-27
9 202321044177-COMPLETE SPECIFICATION [27-06-2024(online)].pdf 2024-06-27
10 202321044177-FORM 3 [01-07-2024(online)].pdf 2024-07-01
11 202321044177-Request Letter-Correspondence [09-07-2024(online)].pdf 2024-07-09
12 202321044177-Power of Attorney [09-07-2024(online)].pdf 2024-07-09
13 202321044177-Covering Letter [09-07-2024(online)].pdf 2024-07-09
14 202321044177-CORRESPONDENCE(IPO)-(WIPO DAS)-16-07-2024.pdf 2024-07-16
15 Abstract1.jpg 2024-09-19